AD-231C

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-231C, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C [Phase 1]